Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
出版年份 2017 全文链接
标题
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
作者
关键词
-
出版物
Chemical Science
Volume 8, Issue 3, Pages 2056-2060
出版商
Royal Society of Chemistry (RSC)
发表日期
2016-11-29
DOI
10.1039/c6sc03655d
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Characterization of antibody–drug conjugates by mass spectrometry: advances and future trends
- (2016) Richard Y.-C. Huang et al. DRUG DISCOVERY TODAY
- Erratum: Corrigendum: Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry
- (2016) Padma Akkapeddi et al. Chemical Science
- Next-generation disulfide stapling: reduction and functional re-bridging all in one
- (2016) Maximillian T. W. Lee et al. Chemical Science
- The use of 3,6-pyridazinediones in organic synthesis and chemical biology
- (2016) Maximillian T. W. Lee et al. JOURNAL OF CHEMICAL RESEARCH
- Design and Synthesis of Tesirine, a Clinical Antibody–Drug Conjugate Pyrrolobenzodiazepine Dimer Payload
- (2016) Arnaud C. Tiberghien et al. ACS Medicinal Chemistry Letters
- Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates
- (2015) Remon van Geel et al. BIOCONJUGATE CHEMISTRY
- A mild TCEP-based para-azidobenzyl cleavage strategy to transform reversible cysteine thiol labelling reagents into irreversible conjugates
- (2015) Antoine Maruani et al. CHEMICAL COMMUNICATIONS
- Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic
- (2015) Antoine Maruani et al. CHEMICAL COMMUNICATIONS
- Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)
- (2015) João P. M. Nunes et al. CHEMICAL COMMUNICATIONS
- In vivo imaging with antibodies and engineered fragments
- (2015) Amanda C. Freise et al. MOLECULAR IMMUNOLOGY
- Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
- (2015) Christopher R. Behrens et al. MOLECULAR PHARMACEUTICS
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
- (2015) Antoine Maruani et al. Nature Communications
- Regioselective and Stoichiometrically Controlled Conjugation of Photodynamic Sensitizers to a HER2 Targeting Antibody Fragment
- (2014) Francesca Bryden et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugation through Glycoengineering
- (2014) Qun Zhou et al. BIOCONJUGATE CHEMISTRY
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
- (2013) Lourdes Castañeda et al. CHEMICAL COMMUNICATIONS
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
- (2013) Felix F. Schumacher et al. Scientific Reports
- -H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)
- (2012) J. Wu et al. CLINICAL CANCER RESEARCH
- Small molecule drugs – optimizing DNA damaging agent-based therapeutics
- (2012) John A Hartley et al. CURRENT OPINION IN PHARMACOLOGY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Site-specific chemical protein conjugation using genetically encoded aldehyde tags
- (2012) David Rabuka et al. Nature Protocols
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
- (2011) Chris P. Ryan et al. CHEMICAL COMMUNICATIONS
- Bromopyridazinedione-mediated protein and peptide bioconjugation
- (2011) Vijay Chudasama et al. CHEMICAL COMMUNICATIONS
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- The development of pyrrolobenzodiazepines as antitumour agents
- (2011) John A Hartley EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ranking the Susceptibility of Disulfide Bonds in Human IgG1 Antibodies by Reduction, Differential Alkylation, and LC−MS Analysis
- (2010) Hongcheng Liu et al. ANALYTICAL CHEMISTRY
- Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs)
- (2010) Dyeison Antonow et al. CHEMICAL REVIEWS
- Chemically modified antibodies as diagnostic imaging agents
- (2010) Jeffrey J Day et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Enhanced System for Unnatural Amino Acid Mutagenesis in E. coli
- (2009) Travis S. Young et al. JOURNAL OF MOLECULAR BIOLOGY
- Development trends for therapeutic antibody fragments
- (2009) Aaron L Nelson et al. NATURE BIOTECHNOLOGY
- Site specific protein labeling by enzymatic posttranslational modification
- (2009) Murat Sunbul et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now